The Emirates Drug Establishment (EDE) announced that it has authorised Inpefa (sotagliflozin), an innovative treatment for ...
Helps individuals living with heart failure, or those at risk of developing it, by reducing complications and lowering the risk of serious cardiovascular problems ...
Dubai, UAE: The Emirates Drug Establishment (EDE) announced that it has authorized Inpefa® (sotagliflozin), an innovative ...
Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.
Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that ...
Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that ...
About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...
The Emirates Drug Establishment announced on Monday it had authorised the use of Inpefa (sotagliflozin), a treatment shown in ...
The study analyzed more than 100 million U.S. medical claims from July 1, 2022, through June 30, 2024, and found that nearly one in three eligible heart failure patients are not being treated with ...
JACC’s new cardiovascular report shows rising risk factors, worsening outcomes, and care gaps in recent years in the US. The ...